Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1971 Feb;47(544):116-9.
doi: 10.1136/pgmj.47.544.116.

L-dopa and amantadine hydrochloride in extra-pyramidal disorders

J D Parkes, R P Knill-Jones, P J Clements

L-dopa and amantadine hydrochloride in extra-pyramidal disorders

J D Parkes et al. Postgrad Med J. 1971 Feb.

Abstract

L-Dopa and amantadine hydrochloride were separately given to patients with diverse extra-pyramidal disorders including progressive supranuclear palsy; porto-systemic encephalopathy; oculogyric crises; drug-induced Parkinsonism; Huntington's chorea, hemiballismus; spasmodic torticollis, familial tremor; and athetosis. Akinesia and rigidity were improved in the first two conditions and simultaneously there was improvement in disordered eye movement. Amantadine provoked an exacerbation in spasmodic torticollis and familial tremor. No other condition was influenced. Both amantadine and L-dopa will facilitate eye movement mechanisms: it seems probable that both drugs act on dopamine-sensitive areas within the CNS. Neither drug will give significant benefit in the above disorders.

PubMed Disclaimer

References

    1. Medicine (Baltimore). 1965 Sep;44(5):345-96 - PubMed
    1. Pharmacol Rev. 1966 Jun;18(2):925-64 - PubMed
    1. N Engl J Med. 1969 Feb 13;280(7):337-45 - PubMed
    1. Brain. 1969;92(3):663-78 - PubMed
    1. Lancet. 1969 Nov 15;2(7629):1066 - PubMed